Filter By Topic:
View All +
News
07.13.20
Newly Developed Virtual Clinics Provide Better Access to Care for Individuals with EpilepsyNews
07.10.20
Strokes Associated with COVID-19 May Be More Severe With Higher MortalityNews
07.10.20
FDA Approves Expanded OnabotulinumtoxinA Label for Pediatric SpasticityNews
07.09.20
Blood Biomarker May Predict Concussion Severity and DurationNews
07.08.20
Aducanumab for Alzheimer Disease Treatment Submitted to FDA for ApprovalNews
07.07.20
FDA Clears Automated ASPECTS Scoring from CTNews
07.07.20
Rare Genetic Mutations Linked to Parkinson Disease Identified in Pilot StudyNews
07.06.20
The Women Neurologist Group and the Alliance for Advancement of Neuroscience Advocate for Continued use of TelemedicineNews
06.30.20
Chronic Stress of Discrimination Increases Hypertension Risk in African AmericansNews
06.30.20
FDA Grants Orphan Drug Designation for Primary Mitochondrial Myopathies TreatmentNews
06.29.20
Improved, But Still Suboptimal Validity in Criteria for Prodromal Parkinson DiseaseNews
06.26.20
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet SyndromeNews
06.25.20
New Resource Center for People Living with Multiple SclerosisNews
06.24.20
Higher Rates of Alzheimer Disease Not Related to Longer Life in WomenNews
06.24.20
Phase 2 Clinical Trial for Stem-Cell Treatment of Alzheimer Disease PlannedNews
06.23.20
FDA Grants Premarket Approval for Neurostimulation System for Chronic Back PainNews
06.22.20
Enrollment Begins for Phase 1b Clinical Trial of T-cell Immunotherapy for Progressive Multiple SclerosisNews
06.18.20
New Indication for Pimavanserin—Dementia Related Psychosis—Submitted to the FDANews
06.17.20
Phase 2 Trial of Tauroursodeoxycholic Acid for Alzheimer Disease Completes EnrollmentChen Zhao, MD; Claire Flaherty, PhD; Paul J. Eslinger, PhD; and Krishnankutty Sathian, MBBS, PhD
Claire Smyth, BSc; David Roberts, BSc; and Kenneth Monaghan, PhD
Melissa W. Ko, MD; Kevin E. Lai, MD; and Devin D. Mackay, MD
